Floatz logo

MITOMYCIN C

Stage IV Appendix Carcinoma AJCC v8

City of Hope Medical CenterSmall moleculePhase 3Active
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Stage IV Appendix Carcinoma AJCC v8 cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
City of Hope Medical Center
Phase 3BB
Irinotecan
City of Hope Medical Center
Phase 3BB
Thalidomide
Wake Forest University Health Sciences
Phase 2B
Palonosetron
Alliance for Clinical Trials in Oncology
Phase 2CCC
Eloxatin
Alliance for Clinical Trials in Oncology
Phase 1CCC

View all 17 →

Same molecule, other indications

MITOMYCIN C is also rated in:

colorectal carcinomaDormant
BB
Indicative ·
67 / 100
View asset →
peritoneal carcinomatosisDormant
BB
Indicative ·
66 / 100
View asset →
anal carcinomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →